Getinge AB Class B
GETI B: XSTO (SWE)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| ?R# | LOCK|$Vc | LOCK|?MX&h@b |
Getinge Earnings: On Track for Full-Year Guidance on Consumables Growth; Shares Fairly Valued
Getinge reported second-quarter 2026 results, with 4.6% organic sales growth and adjusted EBITA margin expanding to 17.6% from 12% year over year. Full-year guidance was maintained at 3%-5% organic sales growth, adjusted for phasing out its surgical perfusion portfolio. Shares rose 9% on the day.
